Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Isis patents antisense oligonucleotides for cancer treatment

Dec. 7, 1998

FDA approves Hycamtin as second-line treatment of small cell lung cancer

Dec. 4, 1998

Maxia initiates pivotal phase III trial with MX-6 for treatment of CIN

Dec. 4, 1998

Accutin, an RGD-containing peptide with angiogenesis-inhibitory activity

Dec. 3, 1998

Adozelesin displays marginal efficacy in previously untreated metastatic breast cancer

Dec. 3, 1998

IntraBiotics receives milestone payment from Pharmacia & Upjohn

Dec. 3, 1998

Lack of cardiotoxicity of SM-5887 confirmed in dogs

Dec. 2, 1998

Taisho discloses new antitumor series

Dec. 2, 1998

Inhibitors of neovascularization (angiogenesis) patented by JT

Dec. 2, 1998

Vical reports delivery of cytokine and antitumor activity using naked DNA gene transfer

Dec. 1, 1998

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...